BioSpace News Archive

The demand within the global D-dimer testing market is expected to rise alongside advancements in medical research and analysis.

Kaltech Co., Ltd., headquartered in Chuo-ku, Osaka, has announced that an experiment to test for 20 minutes the efficacy of a disinfectant deodorizer equipped with the company’s proprietary photocatalytic technology against airborne novel coronavirus in a fixed space confirmed an infectivity suppression effect.

Ipsen, a specialty-care focused biopharmaceutical group, will host a virtual Capital Markets Day to highlight the Group’s new strategic priorities with the aim of driving continued growth and bringing transformative medicines to patients.

Nordic Nanovector ASA announces that it has completed enrolment into the LYMRIT 37-05 Phase 1 clinical trial of Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation.

Strong participation from international syndicate of investors, including Gilde Healthcare, Invus and BioMed Partners

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announced its CEO and CSO Dr. Kunwar Shailubhai will host a conference call on Wednesday, 2 December 2020 at 4:15 p.m. ET to provide updates on the Company.

International medical imaging IT and cybersecurity company Sectra has been selected by Jessa Hospital in Belgium to deliver its software solution for enterprise imaging.

Sosei Group Corporation announces it has entered into a global collaboration and license agreement with Biohaven Pharmaceutical Holding Company Ltd..

Biofidelity Ltd, the cancer diagnostics company, announced the opening of its new headquarters as it continues its significant recruitment ahead of commercialization of its first products.

Engitix Ltd, a biotechnology company with a portfolio of programmes in fibrosis and solid tumours and two significant partnerships based upon its proprietary human extracellular matrix platform, announced the appointment of Eduardo Bravo as Chairman of its Board of Directors.